摘要
目的探讨化学消融联合经皮冠状动脉介入术治疗肥厚型梗阻性心肌病伴冠心病患者的疗效。方法收集我院2012年1月至2015年6月收治的20例肥厚型梗阻性心肌病伴冠心病患者随机分为两组。对照组患者给予化学消融治疗，实验组患者加施经皮冠状动脉介入术治疗，比较两组患者手术前后LVOTPG、心功能分级、LVOT与IVS水平。结果两组患者术后LVOTPG与心功能分级组间比较差异有统计学意义（P〈0．05）；两组患者术后3个月LVOT与IVS水平组间比较差异有统计学意义（P〈0．05）。结论化学消融联合经皮冠状动脉介入术治疗肥厚型梗阻性心肌病伴冠心病患者的疗效显著，具有借鉴性。
Objective To investigate the clinical efficacy of chemical ablation combined with percutaneous coronary intervention in patients with hypertrophic obstructive cardiomyopathy accompanied with coronary heart disease. Methods 20 cases of hypertrophic obstructive cardiomyopathy accompanied with coronary heart disease in our hospital from January 2012 to June 2015 were selected and randomly divided into two groups. Patients in control group were treated with ablation therapy, patients in experimental group were treated with percutaneous coronary intervention treatment on the basis of control group. LVOTPG, NYHA heart function classification, LVOT and IVS levels before and after operation of two groups were compared. Results There were statistically significant differences in postoperative LVOTPG and heart function classification between two groups （/）〈0.05）; there were statistically significant differences in LVOT and IVS levels 3 months after operation between two groups （P〈0.05）. Conclusion Chemical ablation combined with percutan^ous coronary intervention in patients with hypertrophic obstructive ~ardiomyopathy accompanied with coronary heart disease has significant clinical efficacy, with reference. ：
出处
《国际医药卫生导报》
2016年第9期1227-1229,共3页
International Medicine and Health Guidance News
关键词
化学消融
经皮冠状动脉介入术
肥厚型梗阻性心肌病
冠心病
Chemical ablation
Percutaneous cardiomyopathy
Coronary heart disease coronary intervention
Hypertrophic obstructive
